HI TECH PHARMACAL CO INC
Healthcare · Pharmaceutical Preparations · NY · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|
| Revenue | $64.3M | $55.6M | $49.7M | $39.3M |
| Operating income | — | — | — | — |
| Net income | $5.9M | $10.8M | $10.1M | $8.7M |
| Total assets | $295.0M | $279.1M | $203.2M | — |
| Total liabilities | $49.6M | $42.7M | $22.2M | — |
| Equity | $245.4M | $236.4M | $181.0M | $134.8M |
| EPS (diluted) | $0.43 | $0.79 | $0.79 | $0.67 |
| Shares out. | 13.6M | 13.1M | 13.0M | 12.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2013- Operating margin
- —
- Net margin
- 9.2%
- Return on equity
- 2.4%
- Return on assets
- 2.0%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 16.8%
- Debt / equity
- 0.20×
- Book value / share
- $18.07
- Revenue growth (YoY)
- 15.7%
- Net income growth (YoY)
- −45.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2013- Accruals / assets
- −10.1%clean
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Jul 14, 2009
- NT 10-Qmissed a reporting deadline ↗Dec 16, 2002
- NT 10-Qmissed a reporting deadline ↗Sep 12, 2002
- NT 10-Kmissed a reporting deadline ↗Jul 26, 2002
- NT 10-Kmissed a reporting deadline ↗Jul 29, 1999
- NT 10-Kmissed a reporting deadline ↗Jul 28, 1997
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Simpson Bruce WDirector | Oct 1, 2013 | Option exercise | 12,375 | $24.95 |
| Seltzer ReubenOfficer — Vice Chairman, Business Dev't | Oct 2, 2013 | Option exercise | 11,250 | $13.50 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventApr 17, 2014
- Entered a material agreement · Director / officer changeMar 21, 2014
- Results of operationsMar 12, 2014
- Other material eventDec 26, 2013
- Shareholder voteDec 19, 2013
- Results of operationsDec 10, 2013
- Other material eventOct 11, 2013
- Entered a material agreementSep 16, 2013
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GHI-TECH PHARMACAL CO., INC. FORM 15-12GApr 28, 2014
- SC 13D/AApr 21, 2014
- S-8 POSFORM S-8 POSApr 17, 2014
- S-8 POSFORM S-8 POSApr 17, 2014
- S-8 POSFORM S-8 POSApr 17, 2014
- S-8 POSFORM S-8 POSApr 17, 2014
- S-8 POSFORM S-8 POSApr 17, 2014
- S-8 POSFORM 333-139796Apr 17, 2014
- S-8 POSFORM S-8 POSApr 17, 2014
- S-8 POSFORM S-8 POSApr 17, 2014
- S-8 POSFORM S-8 POSApr 17, 2014
- 8-KFORM 8-KApr 17, 2014
- 25-NSEApr 17, 2014
- 8-KMar 21, 2014
- SC 13D/AMar 20, 2014
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.